I tried to post this on IHUB last week and again t
Post# of 30028
Posted On: 03/09/2016 11:35:25 AM
I tried to post this on IHUB last week and again today, but it was blocked for some reason:
I spoke to Gregg Linn a couple weeks ago at AVDX. I called the main number and he answered. We spoke for about 15 minutes- he was a very nice guy. He said he had met with Roche about OvaDx but they basically told him to come back after it was approved. His impression at least for the DX market right now is that BP doesn’t want to take any risk on at all. He said he had been offered toxic loans from 30 different lenders and has turned them all down. He said he will be announcing a finance deal in the near future at favorable terms. He didn’t comment on ESS or AMBS situation.
I sold the last of my AMBS- I lost any hope when GC said he was looking to spin off ESS. He won’t be able to do an IPO- it would cost 2-3 million to do so, so I think he will do something similar to the DX deal and merge ESS with a different entity. AMBS stock will become worthless as we go forward and it is diluted into oblivion. I see .001- .0001 with billions of shares. No one will finance AMBS at this point unless they have it be floorless since they would stand to lose their investment just like the rest of us do. ESS is at least 1 year away from completing phase 2- then months of negotiations, due diligence with a potential partner so probably a couple years away from being able to close a partnership deal. The only hope i see is if GC was to partner in China now and get a big upfront payment, but probably unlikely.
I also spoke to Jeffrey Stephens at International Infusion about a month ago- I was not impressed. He was not reassuring at all and said “it might go to zero or you might make a lot of money” He was unwilling to acknowledge that the leak –out time frames have been coinciding with the road show and Monaco growth Forum dates and only said GC is always out promoting awareness for the Company. That was a red flag to me. His tone on the call did not sit well with me and I should have followed my gut and sold but I hung on for a few more weeks.
I spoke to Gregg Linn a couple weeks ago at AVDX. I called the main number and he answered. We spoke for about 15 minutes- he was a very nice guy. He said he had met with Roche about OvaDx but they basically told him to come back after it was approved. His impression at least for the DX market right now is that BP doesn’t want to take any risk on at all. He said he had been offered toxic loans from 30 different lenders and has turned them all down. He said he will be announcing a finance deal in the near future at favorable terms. He didn’t comment on ESS or AMBS situation.
I sold the last of my AMBS- I lost any hope when GC said he was looking to spin off ESS. He won’t be able to do an IPO- it would cost 2-3 million to do so, so I think he will do something similar to the DX deal and merge ESS with a different entity. AMBS stock will become worthless as we go forward and it is diluted into oblivion. I see .001- .0001 with billions of shares. No one will finance AMBS at this point unless they have it be floorless since they would stand to lose their investment just like the rest of us do. ESS is at least 1 year away from completing phase 2- then months of negotiations, due diligence with a potential partner so probably a couple years away from being able to close a partnership deal. The only hope i see is if GC was to partner in China now and get a big upfront payment, but probably unlikely.
I also spoke to Jeffrey Stephens at International Infusion about a month ago- I was not impressed. He was not reassuring at all and said “it might go to zero or you might make a lot of money” He was unwilling to acknowledge that the leak –out time frames have been coinciding with the road show and Monaco growth Forum dates and only said GC is always out promoting awareness for the Company. That was a red flag to me. His tone on the call did not sit well with me and I should have followed my gut and sold but I hung on for a few more weeks.
(7)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼